Stanford University


Showing 701-710 of 1,261 Results

  • Alison Marsden

    Alison Marsden

    Douglass M. and Nola Leishman Professor of Cardiovascular Diseases, Professor of Pediatrics (Cardiology) and of Bioengineering and, by courtesy, of Mechanical Engineering

    Current Research and Scholarly InterestsThe Cardiovascular Biomechanics Computation Lab at Stanford develops novel computational methods for the study of cardiovascular disease progression, surgical methods, and medical devices. We have a particular interest in pediatric cardiology, and use virtual surgery to design novel surgical concepts for children born with heart defects.

  • Nicole Martinez-Martin

    Nicole Martinez-Martin

    Assistant Professor (Research) of Pediatrics (Biomedical Ethics) and, by courtesy, of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry and Child Development)

    Current Research and Scholarly InterestsNIH/National Institute of Mental Health
    K01 MH118375-01A1
    “Ethical, Legal and Social Implications in the Use of Digital Technology for Mental Health Applications”

    Greenwall Foundation Making a Difference in Bioethics Grant
    “Ethical, Legal and Social Implications of Digital Phenotyping”

  • Olivia Martinez

    Olivia Martinez

    Johnson and Johnson Professor of Surgery

    Current Research and Scholarly InterestsHost-Pathogen interactions; EBV B cell lymphomas; pathways of immune evasion in the growth and survival of EBV B cell lymphomas; mechanisms of graft rejection and tolerance induction; stem cell and solid organ transplantation.

  • Daphne O. Martschenko

    Daphne O. Martschenko

    Assistant Professor (Research) of Pediatrics (Stanford Center for Biomedical Ethics)

    BioDr. Daphne Oluwaseun Martschenko is an Assistant Professor at the Laurie J. Girand Center for Biomedical Ethics at Stanford. Her scholarship identifies novel ways to examine and enhance the ethical and socially responsible conduct, translation, and interpretation of human genetic research.

    Dr. Martschenko is passionate about fostering public and community engagement with controversial scientific research. She has appeared in the New York Times and on numerous podcasts including Freakonomics Radio. Dr. Martschenko’s work is published in publicly accessible media outlets such as Scientific American and The Conversation. In 2023, she was named one of 10 Scientists to Watch by ScienceNews.

    Dr. Martschenko is author of the book What We Inherit: How New Technologies and Old Myths Are Shaping Our Genomic Future, which she wrote with friend and colleague Sam Trejo, a sociologist at Princeton University. Over the past decade, the field of human genetics has rapidly produced a wide range of never-before-seen genomic tools; together, they debate and discuss a range of social, ethical, and policy issues raised by this so-called DNA revolution. Though there’s plenty the two disagree about, they share a firm belief that—in order to successfully navigate the transition to a society where genetic prediction is increasingly accurate and available—it is vital that society take seriously the impact both of DNA and of pernicious genetic myths.

  • Rory Vu Mather

    Rory Vu Mather

    Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine

    BioI'm a future physician-scientist working at the intersection of statistics, machine learning, and neural signal processing. As part of the Harvard/MIT MD-PhD Program, I recently completed my PhD in Medical Engineering & Medical Physics (MEMP) through the Harvard-MIT Health Sciences and Technology (HST) Program.

    Currently I'm a postdoctoral fellow in pediatric anesthesiology with Dr. Jennifer Rabbitts and Dr. Cornelius Groenewald at Stanford, where I apply causal inference methods to large-scale electronic health record data to estimate how intraoperative decisions shape long-term postoperative pain and opioid outcomes in children.

    I'm also interested in medical education and administration, particularly supporting minority populations such as LGBTQIA+ and Vietnamese communities. Outside of science, I bring a background in graphic design, marketing, and brand development for technology companies, universities, and non-profits.

  • Brittany Elizabeth Matheson, PhD

    Brittany Elizabeth Matheson, PhD

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    BioBrittany Matheson, PhD, is a clinical associate professor and licensed clinical psychologist in the Eating Disorders Clinic. She completed her undergraduate degree at Duke University, doctorate from the Joint Doctoral Program in Clinical Psychology at San Diego State University and the University of California, San Diego, and APA clinical internship at Lucile Packard Children’s Hospital Stanford (LPCH)/Children’s Health Council. Dr. Matheson is a certified family-based treatment (FBT) therapist and consultant. She is also the director of the Stanford Eating Disorder Research Program Data Coordination Center and collaborates with colleagues on NIH-funded randomized clinical trials. Dr. Matheson's research interests include examining the psychosocial, neurocognitive, and familial factors related to disordered eating and excess weight gain in youth. She is interested in the development and implementation of evidence-based treatments for youth with disordered eating as well as better understanding factors that influence pediatric bariatric surgery outcomes. Dr. Matheson has specialized research and clinical expertise in the interplay among obesity, disordered eating, and autism spectrum disorder and is the director of psychological services for the LPCH adolescent metabolic and bariatric surgery program. She conducts comprehensive evaluations and provides evidence-based treatments for individuals across the age-spectrum with eating disorders, including anorexia nervosa, bulimia nervosa, binge eating disorder, avoidant/restrictive food intake disorder, and other specified feeding and eating disorders. Her recent research focuses on reducing access to care barriers by digitizing evidence-based treatments and utilizing technology to enhance treatment outcomes.